Literature DB >> 8028941

Angiographic embolization for the treatment of epistaxis: a review of 108 cases.

L Elden1, W Montanera, K Terbrugge, R Willinsky, P Lasjaunias, D Charles.   

Abstract

Ninety-seven patients were referred to the Toronto Hospital (Western Division) between January 1984 and January 1992 for selective angiographic embolization (108 embolizations, including repeat procedures) to control intractable or recurrent severe epistaxis. Eighty-one patients (comprising 94 embolizations) were referred on an emergent basis because of failure of conventional conservative therapy, consisting of anterior and posterior packing. The remaining 16 patients (14 embolizations) were referred electively for recurrent epistaxis. A retrospective review of these cases was performed, with long-term telephone follow-up achieved in over 95% of cases. Embolization safely controlled active hemorrhage in 88% of the emergent cases. The success rate increased to 90% when two cases in which the source of epistaxis was found to be from the internal carotid artery were excluded (because these vessels could not be safely embolized). Of the patients whose epistaxis was initially controlled by embolization, 82% had no further nosebleeds (follow-up time ranged from 2 to 82 months; average, 26.8 months). More than half of the long-term failures were seen in patients with Osler-Weber-Rendu disease. Overall, the mortality rate was 0% and the long-term morbidity rate was 2% (one cerebral vascular accident and one case of skin slough in the territory of the superficial temporal artery.

Entities:  

Mesh:

Year:  1994        PMID: 8028941     DOI: 10.1177/019459989411100110

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  28 in total

1.  Posterior epistaxis: endonasal exposure and occlusion of the branches of the sphenopalatine artery.

Authors:  David Holzmann; Thomas Kaufmann; Paula Pedrini; Anton Valavanis
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-04-29       Impact factor: 2.503

2.  Transarterial endovascular treatment in the management of life-threatening intra- and postoperative haemorrhages after otorhinolaryngological surgery.

Authors:  Andreas Schrock; Mark Jakob; Katharina Strach; Benjamin Pump; Andreas Otto Gerstner; Kai Wilhelm; Horst Urbach; Friedrich Bootz; Susanne Greschus
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-12       Impact factor: 2.503

3.  Role of Endoscopic Internal Maxillary Artery Ligation in Intractable Idiopathic Epistaxis.

Authors:  Vivek Sasindran; Mithra Sara John
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-01-08

Review 4.  [Current aspects in epistaxis].

Authors:  B J Folz; M Kanne; J A Werner
Journal:  HNO       Date:  2008-11       Impact factor: 1.284

Review 5.  The expanding role of interventional radiology in head and neck surgery.

Authors:  Stephen Broomfield; Iain Bruce; Andrew Birzgalis; Amit Herwadkar
Journal:  J R Soc Med       Date:  2009-06       Impact factor: 5.344

6.  Complications of embolization.

Authors:  José I Bilbao; Antonio Martínez-Cuesta; Femín Urtasun; Octavio Cosín
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

7.  Unexpected complications with head and neck hydrogel microsphere particle embolization: A case series and a technical note.

Authors:  Naim N Khoury; Pierre-Olivier Champagne; Marc Kotowski; Jean Raymond; Daniel Roy; Alain Weill
Journal:  Interv Neuroradiol       Date:  2016-10-22       Impact factor: 1.610

8.  Face skin necrosis following embolization for arteriovenous malformations: a case report.

Authors:  Ozgür Tarkan; Ozgür Sürmelioğlu; Ulkü Tuncer; Erol Akgül
Journal:  Oral Maxillofac Surg       Date:  2010-03

9.  Ischemic necrosis of nose and palate after embolization for epistaxis. A case report.

Authors:  Aris Ntomouchtsis; Gregory Venetis; Lambros Zouloumis; Nicolas Lazaridis
Journal:  Oral Maxillofac Surg       Date:  2010-06

10.  Endovascular treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia.

Authors:  K F Layton; D F Kallmes; L A Gray; H J Cloft
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.